Cargando…
Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study—Focus on Formulation in Children
Developing acceptable medicines for children is a complicated task. Several factors must be considered, including age, physiology, texture preference, formulation, and legal framework among others. In the development of new paediatric medicines, these factors are assessed. However, for older medicin...
Autores principales: | Haslund-Krog, Sissel Sundell, Jørgensen, Inger Merete, Dalhoff, Kim, Holst, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406412/ https://www.ncbi.nlm.nih.gov/pubmed/36010126 http://dx.doi.org/10.3390/children9081236 |
Ejemplares similares
-
Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease
por: Haslund-Krog, Sissel Sundell, et al.
Publicado: (2019) -
Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE study
por: Haslund-Krog, Sissel Sundell, et al.
Publicado: (2019) -
Challenges in conducting paediatric trials with off-patent drugs
por: Haslund-Krog, S.S., et al.
Publicado: (2021) -
Oral prednisolone for acute otitis media in children: protocol of a pilot randomised, open-label, controlled study (OPAL study)
por: Ranakusuma, Respati W., et al.
Publicado: (2018) -
Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study)
por: Ranakusuma, Respati W., et al.
Publicado: (2020)